Authors: KUNDU S NICHOLSON N SALYERS A TAITE B SZALONY J LANSKY D

Citation: S. Kundu et al., IN-VITRO ASSESSMENT OF PLATELET INHIBITION WITH BY SC-54701 BY PFA-100(TM), Thrombosis and haemostasis, 1997, pp. 2704-2704

Authors: NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J FREDERICK L SULEYMANOV O KING L PAGE J FEIGEN L

Citation: N. Nicholson et al., BIOLOGICAL-ACTIVITY OF ORBOFIBAN, AN ORALLY-ACTIVE INHIBITOR OF GLYCOPROTEIN IIB IIIA AND PLATELET-AGGREGATION/, Thrombosis and haemostasis, 1997, pp. 2719-2719

Authors: SALYERS A

Citation: A. Salyers, THE REAL THREAT FROM ANTIBIOTICS, Nature, 384(6607), 1996, pp. 304-304

Authors: NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J ZABLOCKI J FEIGEN L GLENN K KELLER B BROSCHAT K HERIN M JACQMIN P LESNE M

Citation: N. Nicholson et al., AN ORALLY-ACTIVE GLYCOPROTEIN-IIB IIIA ANTAGONIST-SC-54684/, Thrombosis and haemostasis, 69(6), 1993, pp. 975-975

Authors: FEIGEN L NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J ZABLOCKI J GLENN K KELLER B HERIN M JACQMIN P LESNE M

Citation: L. Feigen et al., LONG-TERM INHIBITION OF PLATELETS IN DOGS WITH THE ORALLY-ACTIVE ALPHA(IIB)BETA(3) ANTAGONIST-SC-54684, Thrombosis and haemostasis, 69(6), 1993, pp. 1071-1071

Authors: ZABLOCKI J NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J FEIGEN L HERIN M JACQMIN P LESNE M BOVY P TJOENG FS

Citation: J. Zablocki et al., SELECTION OF AN ORALLY-ACTIVE GLYCOPROTEIN-IIB IIIA RECEPTOR ANTAGONIST FOR CLINICAL-TRIALS/, Thrombosis and haemostasis, 69(6), 1993, pp. 1244-1244